Praxis Precision Medicines News

TD Cowen Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating

Moomoo NewsSep 24 07:31 ET

Praxis Precision Medicines (PRAX) Receives a Buy From TD Cowen

TipRanksSep 24 07:27 ET

Praxis Precision Medicine Analyst Ratings

BenzingaSep 10 07:29 ET

H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $120

Moomoo NewsSep 10 06:31 ET

Optimistic Outlook for Praxis Precision Medicines: Buy Rating Justified by Strategic Advancements and Positive Trial Results

TipRanksSep 10 06:23 ET

Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $150

Moomoo NewsSep 5 06:32 ET

Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $143

Moomoo NewsSep 5 06:31 ET

Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $151

Moomoo NewsSep 5 06:31 ET

A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $120 to $170

Moomoo NewsSep 4 09:00 ET

Wedbush Adjusts Price Target on Praxis Precision Medicines to $51 From $48, Maintains Neutral Rating

MT NewswiresSep 4 06:18 ET

Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $145

Moomoo NewsSep 3 08:31 ET

Buy Rating Affirmed for Praxis Precision Medicines Amid Positive Epilepsy Drug Data

TipRanksSep 3 08:17 ET

Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270

Moomoo NewsAug 21 07:33 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT) and Praxis Precision Medicines (PRAX)

TipRanksAug 21 06:53 ET

Buy Rating Justified by Promising Drug Pipeline and Financial Health at Praxis Precision Medicines

TipRanksAug 16 02:29 ET

A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $120 to $145

Moomoo NewsAug 15 09:03 ET

Praxis Precision Med Price Target Maintained With a $134.00/Share by Oppenheimer

Dow JonesAug 14 13:41 ET

Guggenheim Maintains Buy on Praxis Precision Medicine, Raises Price Target to $170

BenzingaAug 14 13:22 ET

A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $120 to $145

Moomoo NewsAug 14 09:00 ET

Truist Financial Reaffirms Their Buy Rating on Praxis Precision Medicines (PRAX)

TipRanksAug 14 07:31 ET